Identification of two new arthritis severity loci that regulate levels of autoantibodies, interleukin-1β, and joint damage in pristane- and collagen-induced arthritis

Arthritis and Rheumatism

Volumn 64, Issue 5, 2012, Pages 1369-1378

  Brenner, Max ^a   Laragione, Teresina ^a   Shah, Anish ^a   Mello, Adriana ^a   Remmers, Elaine F ^b,c   Wilder, Ronald L ^b,d   Gulko, Pércio S ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d PAREXEL INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COLLAGEN TYPE 2; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; PRISTANE; STROMELYSIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTHRITIS; ARTICLE; BONE EROSION; CARTILAGE INJURY; CELL INFILTRATION; CIA3D GENE; CIA3G GENE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE; GENE IDENTIFICATION; GENE LOCUS; HISTOLOGY; JOINT; JOINT INJURY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PRISTANE INDUCED ARTHRITIS; QUANTITATIVE ANALYSIS; RAT; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; STATISTICAL SIGNIFICANCE; SYNOVITIS; SYNOVIUM; TELOMERE;

ANIMALS; ANIMALS, CONGENIC; ARTHRITIS, EXPERIMENTAL; AUTOANTIBODIES; BIOLOGICAL MARKERS; COLLAGEN; COLLAGEN TYPE II; DISEASE PROGRESSION; GENE EXPRESSION; GENETIC MARKERS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-1BETA; JOINTS; METALLOPROTEASES; QUANTITATIVE TRAIT LOCI; RATS; RATS, INBRED F344; SEVERITY OF ILLNESS INDEX; SPECIES SPECIFICITY; SYNOVIAL MEMBRANE; TERPENES;

EID: 84860433203     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.33468     Document Type: Article

References (49)

1. Gregersen PK, Plenge RM, Gulko PS,. Genetics of rheumatoid arthritis. In:, Firestein G, Panayi G, Wollheim FA, editors. Rheumatoid arthritis. 2nd ed. New York: Oxford University Press; 2006. p. 3-14.
2. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75: 330-7.
3. Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis: a genomewide study. N Engl J Med 2007; 357: 1199-209.
4. Marinou I, Maxwell JR, Wilson AG,. Genetic influences modulating the radiological severity of rheumatoid arthritis. Ann Rheum Dis 2010; 69: 476-82.
5. Gulko PS, Kawahito Y, Remmers EF, Reese VR, Wang J, Dracheva SV, et al. Identification of a new non-major histocompatibility complex genetic locus on chromosome 2 that controls disease severity in collagen-induced arthritis in rats. Arthritis Rheum 1998; 41: 2122-31.
6. Remmers EF, Joe B, Griffiths MM, Dobbins DE, Dracheva SV, Hashiramoto A, et al. Modulation of multiple experimental arthritis models by collagen-induced arthritis quantitative trait loci isolated in congenic rat lines: different effects of non-major histocompatibility complex quantitative trait loci in males and females. Arthritis Rheum 2002; 46: 2225-34.
7. Brenner M, Meng HC, Yarlett NC, Joe B, Griffiths MM, Remmers EF, et al. The non-MHC quantitative trait locus Cia5 contains three major arthritis genes that differentially regulate disease severity, pannus formation, and joint damage in collagen- and pristane-induced arthritis. J Immunol 2005; 174: 7894-903.
8. Joe B, Cannon GW, Griffiths MM, Dobbins DE, Gulko PS, Wilder RL, et al. Evaluation of quantitative trait loci regulating severity of mycobacterial adjuvant-induced arthritis in monocongenic and polycongenic rats: identification of a new regulatory locus on rat chromosome 10 and evidence of overlap with rheumatoid arthritis susceptibility loci. Arthritis Rheum 2002; 46: 1075-85.
9. Vingsbo-Lundberg C, Nordquist N, Olofsson P, Sundvall M, Saxne T, Pettersson U, et al. Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats. Nat Genet 1998; 20: 401-4.
10. Lorentzen JC, Glaser A, Jacobsson L, Galli J, Fakhrai-Rad H, Klareskog L, et al. Identification of rat susceptibility loci for adjuvant-oil-induced arthritis. Proc Natl Acad Sci U S A 1998; 95: 6383-7.
11. Furuya T, Salstrom JL, McCall-Vining S, Cannon GW, Joe B, Remmers EF, et al. Genetic dissection of a rat model for rheumatoid arthritis: significant gender influences on autosomal modifier loci. Hum Mol Genet 2000; 9: 2241-50.
12. Wilder R, Remmers E, Kawahito Y, Gulko P, Cannon G, Griffiths M,. Genetic factors regulating experimental arthritis in mice and rats. In:, Theophilopoulos A, editor. Current directions in autoimmunity. Basel: Karger; 1999. p. 121-65.
13. Becker KG, Simon RM, Bailey-Wilson JE, Freidlin B, Biddison WE, McFarland HF, et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci U S A 1998; 95: 9979-84.
14. Amos CI, Chen WV, Lee A, Li W, Kern M, Lundsten R, et al. High-density SNP analysis of 642 Caucasian families with rheumatoid arthritis identifies two new linkage regions on 11p12 and 2q33. Genes Immun 2006; 7: 277-86.
15. Meng H, Griffiths M, Remmers E, Kawahito Y, Li W, Neisa R, et al. Identification of two novel female-specific non-MHC loci regulating collagen-induced arthritis severity and chronicity, and evidence of epistasis. Arthritis Rheum 2004; 50: 2695-705.
16. Vingsbo C, Sahlstrand P, Brun J, Jonsson R, Saxne T, Holmdahl R,. Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol 1996; 149: 1675-83.
17. Brenner M, Meng HC, Yarlett NC, Griffiths MM, Remmers EF, Wilder RL, et al. The non-major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation and joint damage. Arthritis Rheum 2005; 52: 322-32.
18. Remmers EF, Longman RE, Du Y, O'Hare A, Cannon GW, Griffiths MM, et al. A genome scan localizes five non-MHC loci controlling collagen-induced arthritis in rats. Nat Genet 1996; 14: 82-5.
19. Laragione T, Brenner M, Li W, Gulko PS,. Cia5d regulates a new fibroblast-like synoviocyte invasion-associated gene expression signature. Arthritis Res Ther 2008; 10: R92.
20. T) method. Methods 2001; 25: 402-8.
21. Lorentzen JC, Flornes L, Eklow C, Backdahl L, Ribbhammar U, Guo JP, et al. Association of arthritis with a gene complex encoding C-type lectin-like receptors. Arthritis Rheum 2007; 56: 2620-32.
22. Gulko PS, Winchester RJ,. Rheumatoid arthritis. In:, Austen KF, Frank MM, Atkinson JP, Cantor H, editors. Samter's immunologic diseases. 6th ed. Baltimore: Lippincott, Williams & Wilkins; 2001. p. 427-63.
23. Van Zeben D, Breedveld FC,. Prognostic factors in rheumatoid arthritis. J Rheumatol Suppl 1996; 44: 31-3.
24. Gossec L, Dougados M, Goupille P, Cantagrel A, Sibilia J, Meyer O, et al. Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study. Ann Rheum Dis 2004; 63: 675-80.
25. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994; 37: 481-94.
26. Storgard CM, Stupack DG, Jonczyk A, Goodman SL, Fox RI, Cheresh DA,. Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist. J Clin Invest 1999; 103: 47-54.
27. Sone H, Kawakami Y, Sakauchi M, Nakamura Y, Takahashi A, Shimano H, et al. Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice. Biochem Biophys Res Commun 2001; 281: 562-8.
28. Kleinau S, Erlandsson H, Holmdahl R, Klareskog L,. Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement. J Autoimmun 1991; 4: 871-80.
29. Miagkov AV, Kovalenko DV, Brown CE, Didsbury JR, Cogswell JP, Stimpson SA, et al. NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci U S A 1998; 95: 13859-64.
30. Fava RA, Olsen NJ, Postlethwaite AE, Broadley KN, Davidson JM, Nanney LB, et al. Transforming growth factor β 1 (TGF-β1) induced neutrophil recruitment to synovial tissues: implications for TGF-β-driven synovial inflammation and hyperplasia. J Exp Med 1991; 173: 1121-32.
31. Langdon C, Kerr C, Hassen M, Hara T, Arsenault AL, Richards CD,. Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. Am J Pathol 2000; 157: 1187-96.
32. Leung BP, McInnes IB, Esfandiari E, Wei XQ, Liew FY,. Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis. J Immunol 2000; 164: 6495-502.
33. Szekanecz Z, Szegedi G, Koch AE,. Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance. J Investig Med 1998; 46: 27-41.
34. Rioja I, Bush KA, Buckton JB, Dickson MC, Life PF,. Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment. Clin Exp Immunol 2004; 137: 65-73.
35. Joosten LA, Helsen MM, Saxne T, van de Loo FA, Heinegard D, van den Berg WB,. IL-1 α β blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-α blockade only ameliorates joint inflammation. J Immunol 1999; 163: 5049-55.
36. Van de Loo AA, Arntz OJ, Bakker AC, van Lent PL, Jacobs MJ, van den Berg WB,. Role of interleukin 1 in antigen-induced exacerbations of murine arthritis. Am J Pathol 1995; 146: 239-49.
37. Makarov SS, Olsen JC, Johnston WN, Anderle SK, Brown RR, Baldwin AS Jr, al. Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc Natl Acad Sci U S A 1996; 93: 402-6.
38. Jiang Y, Genant HK, Watt I, Cobby M, Bresnihan B, Aitchison R, et al. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. Arthritis Rheum 2000; 43: 1001-9.
39. Chomarat P, Vannier E, Dechanet J, Rissoan MC, Banchereau J, Dinarello CA, et al. Balance of IL-1 receptor antagonist/IL-1 β in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 1995; 154: 1432-9.
40. Neidhart M, Gay RE, Gay S,. Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2000; 43: 1719-28.
41. Ghivizzani SC, Kang R, Georgescu HI, Lechman ER, Jaffurs D, Engle JM, et al. Constitutive intra-articular expression of human IL-1 β following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis. J Immunol 1997; 159: 3604-12.
42. Dinarello CA,. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011; 117: 3720-32.
43. Dechanet J, Merville P, Durand I, Banchereau J, Miossec P,. The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium. J Clin Invest 1995; 95: 456-63.
44. Svensson L, Jirholt J, Holmdahl R, Jansson L,. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 1998; 111: 521-6.
45. Cook AD, Rowley MJ, Mackay IR, Gough A, Emery P,. Antibodies to type II collagen in early rheumatoid arthritis: correlation with disease progression. Arthritis Rheum 1996; 39: 1720-7.
46. Vencovsky J, Machacek S, Sedova L, Kafkova J, Gatterova J, Pesakova V, et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 2003; 62: 427-30.
47. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004; 350: 2572-81.
48. Griffiths MM, Wang J, Joe B, Dracheva S, Kawahito Y, Shepard JS, et al. Identification of four new quantitative trait loci regulating arthritis severity and one new quantitative trait locus regulating autoantibody production in rats with collagen-induced arthritis. Arthritis Rheum 2000; 43: 1278-89.
49. Rintisch C, Kelkka T, Norin U, Lorentzen JC, Olofsson P, Holmdahl R,. Finemapping of the arthritis QTL Pia7 reveals co-localization with Oia2 and the APLEC locus. Genes Immun 2010; 11: 239-45.